Star Health & Allied Insurance Co. Ltd. (IN:STARHEALTH)
:STARHEALTH
Want to see IN:STARHEALTH full AI Analyst Report?
STARHEALTH Stock Chart & Stats
₹459.75
-₹6.80(-1.41%)
At close: 4:00 PM EST
₹459.75
-₹6.80(-1.41%)
Day’s Range― - ―
52-Week Range₹341.15 - ₹586.75
Previous CloseN/A
Volume276.82K
Average Volume (3M)42.40K
Market Cap
₹313.85B
Enterprise Value₹304.03B
Total Cash (Recent Filing)₹0.00
Total Debt (Recent Filing)₹4.70B
Price to Earnings (P/E)52.2
Beta0.74
Next Earnings
Jul 24, 2026EPS Estimate
4.19Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.90
Shares Outstanding588,403,500
10 Day Avg. Volume41,268
30 Day Avg. Volume42,396
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)16.57
Revenue Forecast (FY)₹218.30B
Bulls Say, Bears Say
Bulls Say
Low Leverage / Strong Balance SheetVery low debt and rising equity provide a durable capital buffer for an insurer, supporting solvency, regulatory margins and the ability to absorb claim volatility. This financing conservatism enables long-term underwriting capacity expansion and reduces refinancing risk across cycles.
Improving Cash GenerationStronger recent operating and free cash flow increases internal funding for reserves, reinsurance and distribution investments without reliance on external financing. Reliable cash conversion supports sustainability of underwriting operations and strategic reinvestment over multiple years.
Scale And Profitability RecoveryMulti-year top-line scaling and a return to sustained profitability since 2023 indicate a resilient business model and improved underwriting discipline. Scale across retail and group channels helps diversify risk and supports long-term economies of distribution and claims management.
Bears Say
Revenue Growth SlowdownA sharp deceleration in premium growth reduces operating leverage and constrains future earnings expansion. Persistently slower GWP could reflect pricing pressure, distribution limits or market saturation, making it harder to restore prior earnings momentum over the medium term.
Softening Earnings / ReturnsDeclining net income and a weakening return trend indicate pressure on profitability drivers. If earnings lag capital growth, ROE normalization may persist, limiting retained-earnings-driven growth and reducing flexibility for shareholder distributions or capital deployment.
Underwriting/margin PressureHealth insurers face structural risks from medical inflation, adverse claims experience and fraud; reported underwriting pressure implies higher claim ratios or expense leakage. Persistent margin volatility forces higher pricing or reinsurance costs, harming competitiveness and long-term margin sustainability.
Star Health & Allied Insurance Co. Ltd. News
STARHEALTH FAQ
What was Star Health & Allied Insurance Co. Ltd.’s price range in the past 12 months?
Star Health & Allied Insurance Co. Ltd. lowest stock price was ₹341.15 and its highest was ₹586.75 in the past 12 months.
What is Star Health & Allied Insurance Co. Ltd.’s market cap?
Star Health & Allied Insurance Co. Ltd.’s market cap is ₹313.85B.
When is Star Health & Allied Insurance Co. Ltd.’s upcoming earnings report date?
Star Health & Allied Insurance Co. Ltd.’s upcoming earnings report date is Jul 24, 2026 which is in 84 days.
How were Star Health & Allied Insurance Co. Ltd.’s earnings last quarter?
Star Health & Allied Insurance Co. Ltd. released its earnings results on Apr 28, 2026. The company reported ₹1.9 earnings per share for the quarter, beating the consensus estimate of ₹1.407 by ₹0.493.
Is Star Health & Allied Insurance Co. Ltd. overvalued?
According to Wall Street analysts Star Health & Allied Insurance Co. Ltd.’s price is currently Overvalued.
Does Star Health & Allied Insurance Co. Ltd. pay dividends?
Star Health & Allied Insurance Co. Ltd. does not currently pay dividends.
What is Star Health & Allied Insurance Co. Ltd.’s EPS estimate?
Star Health & Allied Insurance Co. Ltd.’s EPS estimate is 4.19.
How many shares outstanding does Star Health & Allied Insurance Co. Ltd. have?
Star Health & Allied Insurance Co. Ltd. has 588,403,500 shares outstanding.
What happened to Star Health & Allied Insurance Co. Ltd.’s price movement after its last earnings report?
Star Health & Allied Insurance Co. Ltd. reported an EPS of ₹1.9 in its last earnings report, beating expectations of ₹1.407. Following the earnings report the stock price went up 0.349%.
Which hedge fund is a major shareholder of Star Health & Allied Insurance Co. Ltd.?
Currently, no hedge funds are holding shares in IN:STARHEALTH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Star Health & Allied Insurance Co. Ltd.
Star Health and Allied Insurance Company Limited provides health insurance products. It offers retail health products to various customer segments, including individuals, families, students, and senior citizens, as well as persons with pre-existing medical conditions across the middle-market customer segment; and group health insurance policies provide to employees of corporates, including SMEs through company health insurance plans. The company also provides personal accident and travel insurance. It distributes its products through individual agents, brokers, corporate agent banks, other corporate agents, and online channel partners comprising web aggregators, as well as directly to customers. As of September 30, 2021, the company had 779 health insurance branches across 25 states and 5 union territories in India. Star Health and Allied Insurance Company Limited was incorporated in 2005 and is based in Chennai, India.
Technical Analysis
Alembic Pharmaceuticals Limited
―
HealthCare Global Enterprises Ltd.
―
Marksans Pharma Limited
―
Global Health Limited
―
Medi Assist Healthcare Services Limited
―